Cannon Global Investment Management, LLC Sage Therapeutics, Inc. Transaction History
Cannon Global Investment Management, LLC
- $42.2 Million
- Q2 2025
A detailed history of Cannon Global Investment Management, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Cannon Global Investment Management, LLC holds 32,500 shares of SAGE stock, worth $282,100. This represents 0.7% of its overall portfolio holdings.
Number of Shares
32,500Holding current value
$282,100% of portfolio
0.7%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
211Shares Held
50MCall Options Held
790KPut Options Held
440K-
Madison Avenue Partners, LP New York, NY6.08MShares$52.7 Million5.93% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$28.3 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT1.95MShares$16.9 Million0.07% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.92MShares$16.6 Million0.01% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...